Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, octobre 27
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
MDxHealth SA
MDXH
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.1926
-0.0021
-1.08%
Dern. MÀJ: Oct 27, 1:57 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
MDxHealth Financials
MDxHealth (MDXH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.
Avi Kapoor
PRO
MDxHealth Suspends FY2026 Revenue Guidance Of $110M-$115M; Reports Preliminary Q3 Revenue Of About $22.7M vs. $22.7M Year Ago
Benzinga Newsdesk
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.
Vandana Singh
PRO
MDxHealth Affirms FY2026 Sales Guidance of $110.000M-$115.000M vs $98.814M Est
MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.000 million-$115.000 million vs $98.814 million estimate.
Benzinga Newsdesk
PRO
MDxHealth Q2 EPS $(0.18) Misses $(0.16) Estimate, Sales $27.200M Beat $25.884M Estimate
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same
Benzinga Newsdesk
PRO
MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est
MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.000 million-$115.000 million vs $135.912 million estimate.
Benzinga Newsdesk
